Our finding shows that the downregulation of CPB1 results in a decrease in the mRNA expression of TUBB3. Studies suggest that IDC with DCIS component shows a low recurrence rate [53], low-grade, and better survival outcome [54] and that the survival is highest when DCIS is low-grade [55]. This evidence concerns the gene CPB1 and ductal breast carcinoma in situ.